Viewing Study NCT04754334


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2025-12-28 @ 12:06 AM
Study NCT ID: NCT04754334
Status: TERMINATED
Last Update Posted: 2023-02-09
First Post: 2021-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
Sponsor: Oramed, Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-03-16
Start Date Type: ACTUAL
Primary Completion Date: 2023-01-13
Primary Completion Date Type: ACTUAL
Completion Date: 2023-01-13
Completion Date Type: ACTUAL
First Submit Date: 2021-02-08
First Submit QC Date: None
Study First Post Date: 2021-02-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-02-07
Last Update Post Date: 2023-02-09
Last Update Post Date Type: ACTUAL